Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
05/2003
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037851A1 Racemic tamsulosin free base and methods of making the same
05/08/2003WO2003037850A1 Process for resolution of tamsulosin
05/08/2003WO2003037831A2 Method for preparing 4-nitroso-substituted aromatic amine
05/08/2003US20030088128 Diaryl ether condensation reactions
05/08/2003US20030087963 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2465061A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/07/2003EP1308443A2 Method for the preparation of aryl ethers
05/07/2003EP1308436A1 Calcium receptor antagonists
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP0940387B1 Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same
05/06/2003US6559318 Hydrolysis of 1,1,3,3-tetraalkoxyalkane to 3,3-dialkoxypropionaldehyde using acid catalyst; Henry reaction with nitromethane; dehydration, Diels-Alder reaction, hydrogenation, cyanation, saponification
05/06/2003US6559181 A method to treat endometrial carcinoma, prostate cancer, or prostate hyperplasia comprising administering to a patient in need of such treatment an effective dose of a 3,4-Diphenyl-bicyclo(4.3.0)nonyl compound of formula I
05/06/2003US6558433 Oxidation hair dye
05/02/2003EP1305306A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
05/02/2003EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
05/02/2003EP0811006B1 Benzopyran-containing compounds and method for their use
05/01/2003WO2003035603A1 Acetic acid derivatives
05/01/2003WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents
05/01/2003WO2003035008A2 Functionalized stilbene derivatives as improved vascular targeting agents
05/01/2003US20030083525 Reacting 1-naphthols with 2-(N-morpholiny)ethyl chloride forming 1-naphthol ethers which are reacted with hydroxyl-amine hydrochoride and acrylic acid forming 4-(2-((1)-naphthyloxy-(4)-acetamino)ethyl)morpholine
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003CA2463902A1 Functionalized stilbene derivatives as improved vascular targeting agents
05/01/2003CA2463226A1 Acetic acid derivatives
04/2003
04/30/2003CN1414945A Lundry detergent compositions comprising hydrophobically modified polyamines
04/30/2003CN1414944A Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process
04/29/2003US6555510 Bis(perfluoroalkanesulfonyl)imides and their salts as surfactants/additives for applications having extreme environments and methods therefor
04/29/2003CA2123160C Controlled release formulation
04/24/2003WO2003033467A1 Nitroso diphenylamine derivatives as nitrogen monoxide generating agents
04/24/2003US20030078454 Process for producing 1,3-bis (3-aminophenoxy) benzene
04/24/2003US20030078264 Treating atherosclerosis and other coronary artery diseases
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1303525A1 Production of novel phosphane ligands and use in catalytical reactions
04/23/2003EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
04/23/2003EP1093450B1 Desformoterol and process for its preparation
04/23/2003EP1051389B1 Method for producing oxalkylated amines or alcohols
04/23/2003CN1413185A Substitued 1 and 2 naphthol mannich bases
04/23/2003CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
04/23/2003CN1106215C Alkylated aminoether surfactant
04/22/2003US6552229 Method for preparing 4-nitroso-substituted aromatic amine
04/22/2003US6552161 Fluorinated diamine; it's polyamic acid and polyimide with at least one tetracarboxylic dianhydride
04/22/2003US6552088 Biphenyl derivatives
04/17/2003WO2003031389A1 Abscisic acid biosynthesis inhibitor
04/17/2003US20030073867 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof
04/17/2003US20030073846 Aminoalcohol derivatives
04/17/2003US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same
04/17/2003CA2462689A1 Inhibitor against biosynthesis of abscisic acid
04/16/2003EP1302527A1 Process for the preparation of polyalkylphenoxyaminoalkanes
04/16/2003EP1301498A1 Colchinol derivatives as angiogenesis inhibitors
04/16/2003EP1301496A2 Novel coupling components for oxidation colouring agents
04/16/2003EP0972769B1 Novel amide derivatives and medicinal compositions thereof
04/16/2003CN1411435A Novel use of phenyl hetero alkylamine derivatives
04/15/2003US6548704 Reacting an optically active amine in the presence of hydrogen and a hydrogenation or dehydrogenation catalyst containing copper and zinc oxide catalyst on a support
04/15/2003US6548461 Subjecting polyalkylene alcohol polyalkoxylates to a reductive amination with ammonia, monoamines or polyamines using hydrogenation catalyst
04/10/2003WO2003029208A2 Method for producing vanillylamine hydrochloride
04/10/2003WO2003029189A1 Process for producing (2-nitrophenyl)acetonitrile derivative and intermediate therefor
04/10/2003WO2003029186A1 Synthesis of (±)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
04/10/2003WO2003029185A1 Novel compounds
04/10/2003WO2003029184A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant
04/10/2003US20030069448 Organic luminescent material for flat panel displays, emits intense yellow or red light; efficient production
04/10/2003US20030069310 Salicylic acid salts of salmeterol
04/10/2003US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives
04/10/2003CA2463232A1 Process for producing (2-nitro-phenyl)acetonirtile derivative and intermediate used for synthesis thereof
04/10/2003CA2462108A1 Synthesis of (.plusmn.)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
04/09/2003EP1300402A1 Alkoxybenzylamines with antimicrobial properties
04/09/2003EP1300381A1 Process for preparing optically active alcohols
04/09/2003EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
04/09/2003EP1299342A1 Method for producing 3,3-diarylpropylamines
04/09/2003EP1299070A1 Novel quaternary ammonnium compounds and process for preparing and using same
04/09/2003CN1408703A New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method
04/08/2003US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
04/08/2003US6544974 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
04/03/2003WO2003012253A3 Method of controlling asphaltene precipitation in a fluid
04/03/2003WO2002058632A3 Primary intermediates for oxidative coloration of hair
04/03/2003US20030065223 Reacting vanilla with hydroxylamine; forming oxime; catalytic hydrogenation
04/03/2003US20030065221 Synthesis of (+/-)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065174 Antiinflammatory agents; analgesics
04/03/2003US20030065128 Low absorption, low double refraction; for use as the core and cladding layers in optical thin film devices (electrooptics)
04/03/2003US20030065039 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
04/03/2003US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
04/03/2003US20030064980 Respiratory system disorders; antiinflammatory agents
04/02/2003EP1296933A1 Self-reducible copper(ii) source reagents for chemical vapor deposition of copper metal
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP1077924B1 Ethoxylated quaternary ester compounds
04/02/2003EP0874615B1 Colorants for colouring keratin fibres
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541668 Methods for preparing 3-arloxy-3-arylpropylamines and intermediates thereof
04/01/2003US6541129 Organic electroluminescence device and phenylenediamine derivative
04/01/2003US6540793 Coupler for use in oxidative hair dyeing
03/2003
03/28/2003WO2002030869A1 5-amino-1-pentene-3-ol substituted derivatives
03/28/2003CA2424103A1 Substituted 5-amino-1-penten-3-ol derivatives
03/27/2003WO2003024917A1 Bridged p-phenylenediamines
03/27/2003WO2003024916A1 Crystals of hydroxynorephedrine derivative
03/27/2003WO2003024440A1 Salicylic acid salts, methods for the production and use thereof as medicaments
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2002030915A3 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport
03/27/2003US20030059536 Lanthanum complex and process for the preparation of a BLT layer using same
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 140